[22] [23] GHK-Cu has been found to induce a systemic enhancement of healing in rats, mice, and pigs
(NOTE: There is an ongoing debate about whether 5-Amino 1MQ should be classified as a small molecule or a peptide, but thats a discussion far beyond the scope of this article) It was discovered in 2017 by researchers at the University of Texas who were attempting to discover small, selective, and membrane-permeable inhibitors of an enzyme called nicotinamide N -methyltransferase (NNMT)
Early animal and small human studies suggest it is generally well tolerated in the short term, but we do not yet have large, longterm trials
5-Amino-1-methylquinolin-1-ium Iodide, 5-amino-1MQ, Purity 98% Min, 5 grams powder, CAS No
Early inflammatory phase benefits from both peptides' immunomodulatory effects, preventing excessive inflammation that can impair healing